// App-Quantinova.ai

6545.0 : Radiomic response evaluation of recurrent or metastatic head and neck squamous cell cancer (R/M HNSCC) patients receiving pembrolizumab on KEYNOTE-012 study.

Researchers

Presenter

  • Kirsty Taylor

Principal Investigators

  • Michal Kazmierski

  • Astrid Billfalk-Kelly

  • Farnoosh Khodakarami

  • Brandon Driscoll

  • Lisa Wang

  • Scott Victor Bratman

  • Benjamin Haibe-Kains

  • Lillian L. Siu

Medical Centers

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • Department of Medical Biophysics, Toronto, ON, Canada

  • Princess Margaret Cancer Centre University Health Network, Toronto, Ontario, Canada

  • Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, ON, Canada

  • Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Pembrolizumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved